Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562.
2055024-44-5 | Propargyl-peg3-sulfone-peg3-propargyl | AA019E3Z | MFCD30182062
2086689-01-0 | N-(Azido-PEG2)-N-Boc-PEG3-acid | AA019E8A | MFCD30723278
2128735-22-6 | N-Mal-n-bis(peg4-amine) tfa salt | AA019ED1 | MFCD31692216
150152-64-0 | BDP TR carboxylic acid | AA019EGR | MFCD31580083
236406-44-3 | tert-butyl (3aS,8aR)-6-benzyl-1,3,3a,4,5,7,8,8a-octahydropyrrolo[3,4-d]azepine-2-carboxylate | AA019EK0 | MFCD31579921
934625-02-2 | 2-Piperazinemethanol, 2-methyl- | AA019EMW | MFCD19227122
848678-60-4 | Methyl 3-amino-6-fluoro-2-methylbenzoate | AA019EQH | MFCD20702638
1567667-05-3 | Benzoic acid, 5-(hydroxymethyl)-2-(trifluoromethyl)-, methyl ester | AA019ETF | MFCD31641283
1998216-00-4 | 3-(Piperazin-1-yl)benzoic acid hydrochloride | AA019EWJ | MFCD30187530
336105-31-8 | (R)-N-((S)-1-(4-Bromophenyl)-2,2,2-Trifluoroethyl)-2-Methylpropane-2-Sulfinamide | AA019EZM | MFCD30472008